查詢結果分析
相關文獻
- 乳癌婦女接受化學治療導致手足症候群臨床評估及護理處置
- 轉移性乳癌的化學治療
- 一位乳癌患者接受乳房切除與化學治療的護理經驗
- 乳癌的化學治療
- 轉移性乳癌化學治療之新利器--微脂體包覆化學藥物Liposomal Doxorubicin
- 乳癌病人用藥依從性及相關因素之研究
- Fatigue and Related Factors in Women with Breast Cancer Receiving Chemotherapy
- Factors Related to Quality of Life in Breast Cancer Patients Receiving Chemotherapy
- MVP (Mitomycin-C, Vinblastine, Cisplatin) Salvage Chemotherapy for Relapsed and Refractory Metastatic Breast Cancer
- High-Dose Chemotherapy with Autologous Peripheral Blood Stem-Cell Support for High-Risk Primary Breast Cancer
頁籤選單縮合
題 名 | 乳癌婦女接受化學治療導致手足症候群臨床評估及護理處置=Clinical Evaluation and Nursing Management of Hand Foot Syndrome in Breast Cancer Patients Received Chemotherapy |
---|---|
作 者 | 許雅惠; 沈雯琪; 陳淑卿; | 書刊名 | 腫瘤護理雜誌 |
卷 期 | 17:2 2017.12[民106.12] |
頁 次 | 頁17-26 |
專 輯 | 癌症病人的皮膚照護 |
分類號 | 419.77 |
關鍵詞 | 乳癌; 化學治療; 手足症候群; 皮膚毒性反應; Chemotherapy; Skin toxicity reaction; Clinical evaluation; Nursing management; |
語 文 | 中文(Chinese) |
中文摘要 | 手足症候群是使用聚乙二醇化的脂質體阿黴素(pegylated liposomal doxorubicin, PLD)、截瘤達(capecitabine)和5-FU、德薩(Cytarabine)及紫杉醇(docetaxel)等化學治療藥物引起的皮膚毒性反應,會影響執行日常活動及導致生活品質降低,可能導致治療中斷或影響治療療效。本文主要探討化學治療導致手足症候群病理生理機轉、臨床表徵、主客觀評估工具及處置,期能提供護理人員臨床照護參考。 |
英文摘要 | Hand-foot syndrome (HFD) is a skin toxicity reaction caused by chemotherapy such as pegylated liposomal doxorubicin (PLD), capecitabine, 5-FU, cytarabine, and docetaxel. Hand-foot syndrome often interferes with daily life and has negative impacts on the quality of life. These conditions, as a result, may lead to interruption of treatment and negative treatment efficacy. This article aimed to explore the pathology mechanism, symptom, subjective and objective assessment tools and related management. This article should help nurses as a reference in caring for similar patients in the future. |
本系統中英文摘要資訊取自各篇刊載內容。